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Abstract
Background: Salmonella enterica serovar Dublin is a zoonotic infection that can be transmitted from cattle to
humans through consumption of contaminated milk and milk products. Outbreaks of human infections by
S. Dublin have been reported in several countries including high-income countries. A high proportion of S. Dublin
cases in humans are associated with invasive disease and systemic illness. The genetic basis of virulence in S. Dublin
is not well characterized.
Methods: Whole genome sequencing was applied to a set of clinical invasive and non-invasive S. Dublin isolates
from different countries in order to characterize the putative genetic determinants involved in the virulence and
invasiveness of S. Dublin in humans.
Results: We identified several virulence factors that form the bacterial invasome and may contribute to increasing
bacterial virulence and pathogenicity including mainly Gifsy-2 prophage, two different type 6 secretion systems
(T6SSs) harbored by Salmonella pathogenicity islands; SPI-6 and SPI-19 respectively and virulence genes; ggt and
PagN. Although Vi antigen and the virulence plasmid have been reported previously to contribute to the virulence
of S. Dublin we did not detect them in all invasive isolates indicating that they are not the main virulence
determinants in S. Dublin.
Conclusion: Several virulence factors within the genome of S. Dublin might contribute to the ability of S. Dublin
to invade humans’ blood but there were no genomic markers that differentiate invasive from non-invasive isolates
suggesting that host immune response play a crucial role in the clinical outcome of S. Dublin infection.
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Background
Salmonellosis is one of the most common foodborne
diseases worldwide. Salmonella enterica (S. enterica)
causes a huge global burden of morbidity and mortality
in humans. It is estimated that Salmonella serovars
responsible for typhoid fever kill over 250,000 humans
each year [1] while non-typhoidal Salmonella (NTS)
serovars that are responsible for diarrhoeal illness cause
155,000 deaths annually [2]. Moreover, NTS might have
adapted to cause invasive disease and systemic infections
in humans; children, the elderly and immunocomprom-
ised and it is estimated that 680,000 people die every
year as a result of infection by invasive NTS (iNTS) [3].
The most predominant iNTS serovars associated with
systemic illness in humans are S. Typhimurium, S.
Choleraesuis and S. Dublin [4, 5]. S. Dublin is specifically
adapted to cattle [6] thus, people can be infected
through contact with infected animals or consumption
of contaminated food including raw milk and raw-milk
cheese. Outbreaks of human S. Dublin infection have
been reported in some European countries including
Ireland and France [7, 8].
Several virulence factors have been identified within
the human adapted serovars Typhi and Paratyphi [9, 10].
On the other hand, little is known about the molecular
basis of virulence in iNTS more specifically S. Dublin.
Our understanding of the genetic basis of invasiveness
in S. Dublin is skewed by the fact that most studies have
focused on the most common iNTS; S. Typhimurium in
particular the highly invasive multidrug-resistant (MDR)
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S. Typhimurium of a distinct Multilocus Sequence Type
(MLST), ST313 that has been associated with severe in-
fections and deaths in humans in sub-Saharan Africa
[11, 12].
The aim of this study is to characterise the invasome
of S. Dublin and the virulence factors that might enable
the bacteria to invade blood causing systemic illness. We
therefore applied whole genome sequencing (WGS) to a
set of S. Dublin isolates from different countries all over
the world.
Methods
Bacterial strains and whole genome sequencing
A set of S. Dublin isolates from different countries
(Table 1) submitted to Centre National de Référence des
Salmonella, Institut Pasteur were selected for WGS. The
Table 1 Salmonella Dublin strains included in this study
Isolate ID Country (isolation year) Source MLST rMLST Plasmid replicons profile
WS247 Ireland (1929) Human stool 10 53 incX1 and incFII
SARB13 France (1982) Cattle 73 ND incFII
92.9894 Burkina Faso (1992) Human blood 10 53 incX1 and incFII
93.1086 France (1992) Cattle 10 53 incX1, incFIA and incFIB
93.3170 Cameron (1993) Human blood 10 53 No plasmid replicons
93.5462 Mali (1993) Human blood 10 53 incX1, incFII and IncQ1
93.1557 Senegal (1993) Human stool 10 53 No plasmid replicons
94.2023 France (1994) Cattle 10 53 incX1 and incFII
94.8298 Togo (1994) Human blood 10 53 incX1 and incFII
98.5329 France (1998) Human blood 10 53 incX1 and incFII
99.5828 Benin (1999) Human blood 2037 53 incX1 and incFII
99.6207 Benin (1999) Human blood 10 53 incX1 and incFII
00.8531 France (2000) Milk 10 53 incX1 and incFII
00.7892 France (2000) Shellfish 10 53 incX1 and incFII
01.9588 France (2001) Human blood 10 53 incX1 and incFII
01.9808 France (2001) Human blood 10 53 incX1 and incFII
02.5213 Côte d’ivoire (2002) Human blood 10 53 incX1 and incFII
02.1212 France (2002) Milk 10 53 incX1 and incFII
02.1209 France (2002) Pork meat 10 53 incX1 and incFII
02.9836 France (2002) Human stool 10 53 incX1 and incFII
03.2892 France (2003) Human urine 10 53 incX1 and incFII
04.4663 Cameron (2004) Human blood 73 ND incX1 and incFII
05.1078 France (2005) Human blood 10 53 incX1 and incFII
05.6136 Mali (2005) Human blood 10 53 incX1 and incFII
05.5914 Togo (2005) Human stool 10 53 incX1 and incFII
05.2324 Peru (2005) Human blood 10 53 incX1, incFII and IncQ1
08.6645 Congo (2008) Human blood 10 53 incX1 and incFII
09.2054 France (2009) Human stool 10 53 incX1 and incFII
201,001,882 France (2010) Human blood 10 53 incX1 and incFII
201,005,507 Nigeria (2010) Human blood 10 53 No plasmid replicons
201,200,014 France (2012) Human blood 10 53 incX1 and incFII
201,200,083 France (2012) Human urine 10 53 incX1 and incFII
201,208,251 France (2012) Human pus 73 ND incX1 and incFII
201,200,586 Maurice island (2012) Human stool 10 53 incX1 and incFII
201,208,243 Thailand (2012) Human blood 10 53 incX1 and incFII
All S. Dublin isolates do not harbor ARGs except two isolates; 93.5462 harbours ARGs to aminoglycoside, phenicol and sulphonamide while the isolate 05.2324
harbours ARGs to aminoglycoside, beta-lactam, sulfonamide and trimethoprim
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set of isolates included 22 human invasive isolates; 19
isolates from blood and 2 isolates from urine in addition
to one isolate from pus. For comparison, we included 6
clinical non-invasive isolates from stool and 7 veterinary
isolates. We also included the original S. Dublin isolate
isolated from the stool of a patient in Dublin, Ireland
(WS247) in 1929 giving the name of Dublin serovar.
Furthermore, the reference S. Dublin isolate; SARB13
isolated in France from cattle in 1982 [13] was also in-
cluded in this study.
WGS was carried out by the Center for Genomic
Epidemiology at the Technical University of Denmark
where genomic DNA was prepared for Illumina pair-
end (PE) sequencing using the Illumina (Illumina, Inc.,
San Diego, CA) NexteraXT® Guide 150,319,425,031,942
following the protocol revision C (http://support.illumina.-
com/downloads/nextera_xt_sample_preparation_guide_150
31942.html). A sample of the pooled NexteraXT Libraries
was loaded onto an Illumina MiSeq reagent cartridge using
MiSeq Reagent Kit v2 and 500 cycles with a Standard Flow
Cell. The libraries were sequenced using an Illumina
platform and MiSeq Control Software 2.3.0.3. All isolates
were pair-end sequenced using 100 bp PE libraries. Raw
sequence data have been submitted to the European
Nucleotide Archive (http://www.ebi.ac.uk/ena) under study
accession no.: PRJEB17616 (http://www.ebi.ac.uk/ena/data/
view/PRJEB17616).
Bioinformatic analysis
The quality of the raw sequence data was evaluated
using FastQC toolkit (http://www.bioinformatics.babraham.
ac.uk/projects/fastqc/). Low quality reads were removed
using ea.-utils package (https://expressionanalysis.github.io/
ea-utils/). PE reads were assembled using Velvet [13] and
the best possible assembly with the highest N50 value was
annotated using RAST server [14]. The assembled se-
quences were analyzed to detect the sequence type (ST) of
S. enterica, plasmid replicons and acquired antimicrobial
resistance genes (ARGs) using MLST, PlasmidFinder
and ResFinder respectively available from Center for
Genomic Epidemiology (CGE) https://cge.cbs.dtu.dk//ser-
vices/all.php. Ribosomal MLST (rMLST) was determined
using Enterobase https://enterobase.warwick.ac.uk/
PE reads from each isolate were mapped against the ref-
erence genome of S. Dublin strain CT_02021853
(accession number: NC_011205.1) using Burrows Wheeler
Aligner (BWA) [15]. Single nucleotide polymorphisms
(SNPs) were identified using samtools mpileup [16]. The
best-fit model for nucleotides substitution was determined
by jModelTest [17] then a maximum likelihood (ML)
phylogeny based on SNPs was constructed by MEGA6
software [18] using 1000 bootstrap replicates.
BLASTn [19] was used for the alignment of virulence
genes and genomic regions. Blast Ring Image Generator
(BRIG) was used to illustrate the presence/absence of
the virulence determinants [20].
Results
Putative virulence regions and genes in S. Dublin
Vi-coding genes harboured by Salmonella Pathogenicity
Island (SPI); SPI-7 were absent from all S. Dublin iso-
lates except three isolates including the reference cattle
isolate; SARB13 and two clinical isolates; 04.4663 from
blood and 201,208,251 from pus (Fig. 1).
Interestingly, genes coding for flagellum biosynthesis
were identical among invasive and non-invasive isolates.
All S. Dublin isolates except these three isolates;
SARB13, 04.4663 and 201,208,251 harbour the putative
virulence gene st313-td on the degraded pathogenicity
island ST313-GI (Fig. 2) which is entirely absent from
the Vi positive three isolates (SARB13, 04.4663 and
201,208,251).
On the other hand, all S. Dublin isolates sequenced in
this study harbour pathogenicity islands SPI-6 and SPI-19
that encode type VI secretion system (T6SS); T6SSSPI-6
and T6SSSPI-19 respectively and they are all lysogenic for
Gifsy-2 prophage (Fig. 3) that harbor the gene encoding
Gifsy-2 prophage attachment and invasion protein.
An accessory genome that is identical to the viru-
lence plasmid pCT02021853_74 (accession number:
NC_011204.1) that harbor the virulence spv locus was
detected in all S. Dublin isolates (plasmid replicons;
incX1 and incFII) expect three clinical isolates; includ-
ing 93.1557 from stool and 93.3170 and 201,005,507
from blood that harbour no plasmids altogether. On
the other hand, the cattle isolate 93.1086 has a similar
but smaller plasmid than the virulence plasmid
pCT02021853_74 that lacks the virulence spv locus as
a result of internal deletion.
Interestingly, the clinical invasive isolates; 93.5462 from
Mali and 05.2324 from Peru harbour another plasmid;
plasmid ST4/74 of S. Typhimurium (accession number:
CP002490) and plasmid pSBLT of S. Typhimurium (acces-
sion number: LN794247) respectively in addition to the
virulence plasmid pCT02021853_74 of S. Dublin.
All S. Dublin isolates including clinical and veterinary
isolates harbor putative virulence factors including ggt
and PagN genes that encode for γ-glutamyl transpepti-
dase (GGT) and an outer membrane protein respect-
ively. The distribution of the putative virulence factors
among all S. Dublin isolates are provided in Additional
file 1: Table S1.
Antimicrobial resistance genes present in S. Dublin
isolates
No acquired ARGs were detected in S. Dublin isolates
except in two clinical invasive isolates from blood in-
cluding isolate 93.5462 isolated in 1993 from Mali that
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harbours ARGs to aminoglycoside (strA, strB, and aadA1),
phenicol (catA1) and sulphonamide (sul1 and sul2) on the
plasmid ST4/74 of S. Typhimurium and isolate 05.2324
isolated from Peru in 2005 that has ARGs to aminoglyco-
side (strA, strB, and aadA1 and aac(3)-IIa), beta-lactam
(blaTEM-1B), sulfonamide (sul1 and sul2) and trimetho-
prim (dfrA1) on the plasmid pSBLT of S. Typhimurium.
Phylogenetic relationship among S. Dublin isolates
The phylogenetic SNP analysis showed that invasive and
gastroenteritis isolates were intermixed as SNPs were ran-
domly distributed around the chromosome of S. Dublin.
All isolates except three isolates; SARB13 from cattle,
201,208,251 from human pus and 04.4663 from human
blood, were very closely related (Fig. 4), showed higher
divergence from the other isolates and they have a dis-
tinct MLST (ST-73) and a distinct rMLST while other S.
Dublin isolates have ST-10 except one isolate; 99.5828
that have ST-2037 but they all have the same rMLST; 53
(Table 1).
Discussion
Human infection with iNTS represents a significant
public health problem. A high proportion of S. Dublin
cases in humans are characterized by bloodstream infec-
tion. Furthermore, the antibiotic resistance is increasing
in S. Dublin as we detected two clinical isolates from
blood that are resistant to multiple antibiotics.
The invasiveness of S. Dublin may be related to the ex-
pression of the Vi (virulence) antigen which is a capsular
polysaccharide antigen commonly found in the human
adapted S. Typhi and S. Paratyphi C. It has however also
been detected in S. Dublin [21].
The Vi proteins are encoded within the viaB (Vi
capsule biosynthesis) locus on SPI-7 [22, 23]. The viaB
locus contains both Vi antigen biosynthetic genes
(tviB, tviC, tviD and tviE) and export genes (vexA,
vexB, vexC, vexD and vexE). The expression of Vi anti-
gen is controlled by the rcsB-rcsC and ompR-envZ
two-component regulator systems which lie outside
the SPI-7 they however, interact with tviA; the first
gene of the viaB gene cluster and regions upstream of
the tviA promoter [24].
Experimental studies showed that Vi antigen is antiop-
sonic and antiphagocytic as it reduces the level of S.
Typhi-induced tumor necrosis factor alpha (TNFα) by
human macrophages and it also increases the resistance
of S. Typhi to oxidative stress [25, 26].
Fig. 1 Complete genome alignment of S. Dublin isolates from France. The viaB operon is present in the reference S. Typhi str. CT18 (accession
number: AL513382) but absent from all S. Dublin isolates sequenced in this study except three isolates including an isolate from human blood
(04.4663), an isolate from human pus (201208251) and the reference SARB13 isolate from cattle
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In this study, we screened all S. Dublin isolates from
France for the viaB operon and we found that Vi-coding
genes were absent from all isolates except three isolates
including the reference veterinary isolate; SARB13 and
two clinical isolates; 04.4663 from blood and 201,208,251
from pus. We therefore conclude that it is unlikely that Vi
antigen is the main virulence determinant for S. Dublin
since it is absent from other invasive isolates from blood
and urine.
Although Vi capsular polysaccharide antigen was not
present in all invasive isolates it is possible that S. Dublin
produces a unique O-antigen capsule that plays a role in
increasing bacterial virulence and pathogenicity. Further
in vitro and in vivo studies using O-antigen capsule defi-
cient mutant are required to confirm this hypothesis.
Flagellum is considered as a virulence factor for
motile bacteria such as Salmonella [27]. The surface
domains of the flagellin protein are highly immuno-
genic and play an important role in triggering host in-
nate and adaptive immune responses therefore, motile
bacteria have evolved several mechanisms to overcome
flagellin recognition by host receptors [28] however we
detected no diversity among invasive an non-invasive S.
Dublin strains in flagellar biosynthesis genes including
fliC gene coding for flagellin, fliD coding for the fla-
gellum capping protein and fliA coding for flagellum-
specific sigma factor.
Although the three S. Dublin isolates; 04.4663,
201,208,251 and SARB13 are positive for the Vi antigen
they lack the novel pathogenicity island ST313-GI that
harbours the putative virulence gene st313-td. On the
other hand, all other S. Dublin isolates harbour the
st313-td gene on a degraded ST313-GI.
Although the exact role of st313-td in increasing
bacterial virulence is not known experimental studies
showed that st313-td is associated with the virulence
and systemic infection in invasive S. Typhimurium of a
distinct MLST, ST313, that has emerged recently in
Africa [12]. It has been shown that virulence of S. Typhi-
murium in the mouse model was reduced in the absence
of st313-td therefore, it is hypothesised that st313-td
might help in bacterial evasion from host’s immune sys-
tem through decreasing the binding of the bacteria to
specific antibodies causing less uptake by macrophages
or through decreasing the susceptibility to complement
mediated lysis [11, 28].
Fig. 2 Complete genome alignment of S. Dublin isolates from France. The novel genomic island ST313-GI harbouring the gene st313-td is present
in the invasive S. Typhimurium str. D23580 (accession number: FN4244051) however they are absent from the three Vi antigen positive S. Dublin
isolates (04.4663, 201,208,251 and SARB13). The other S. Dublin isolates harbour the putative virulence gene st313-td despite that the genomic
island ST313-GI is degraded
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We hypothesise that it is likely that st313-td plays a
role in the virulence of S. Dublin hence, we detected it
in all isolates (except the three isolates that are positive
for Vi antigen; 04.4663, 201,208,251 and SARB13)
however further experimental work is required to test its
role in the virulence of S. Dublin.
There are other mobile genetic elements (MGEs)
(excluding SPI-7 harbouring Vi antigen and genomic
island ST313-GI encoding the putative virulence gene
st313-td) that might also contribute to the virulence
of S. Dublin in humans including SPI-6 and SPI-19
which harbour two different types of T6SS including
T6SSSPI-6 and T6SSSPI-19 respectively.
It has been shown that T6SSs play a significant role in
bacterial pathogenesis as they function as contractile nano-
machines to puncture human cells and deliver virulence
and lethal factors [29]. Experimental studies showed that
T6SSSPI-6 plays a crucial role in the invasiveness and the
systemic spread of S. Typhimurium [30] while T6SSSPI-19
has been reported to contribute to the survival of the
poultry adapted serovar S. Gallinarum within infected mac-
rophages [31].
All S. Dublin isolates harbour SPI-6 and SPI-19 that
encode T6SSSPI-6 and T6SSSPI-19 respectively. Interest-
ingly, SPI-6 and SPI-19 harbouring the two different
T6SS have been also detected in clinical human isolates
from Ireland including invasive and gastroenteritis iso-
lates [32] suggesting that they contribute to the ability of
S. Dublin to cause invasive disease in humans.
Another MGE that might contribute to the virulence
and pathogenesis of Salmonella serovars including S.
Dublin is the lambdoid prophage Gifsy-2 [33] as it
encodes several virulence genes including sodCI, sseI and
gtgE [34].
In this study, we found that all S. Dublin isolates
are lysogenic for Gifsy-2 prophage and they all harbor
the gene encoding Gifsy-2 prophage attachment and
invasion protein suggesting that Gifsy-2 might be as-
sociated with the predisposition of S. Dublin to cause
systemic illness in humans.
Plasmids are other MGEs that have been shown to
play a significant role in the acquisition of virulence and
antimicrobial resistance genes in several Salmonella
serovars [35]. Experimental studies showed that S.
Dublin plasmid encoding the virulence spv locus is in-
volved in the dissemination and spread of bacteria to the
blood [36, 37].
Interestingly, all S. Dublin isolates sequenced in this
study except three clinical isolates including 93.3170 and
201,005,507 from blood and 93.1557 from stool harbour
the virulence S. Dublin plasmid pCT02021853 that en-
codes the spv genes. Although the cattle isolate (93.1086)
Fig. 3 Complete genome alignment of S. Dublin isolates from France. S. Dublin str. CT_02021853 (accession number: NC_011205.1) is used as a
reference. Gifsy-2 like prophage (accession number: NC_010393) and the two different T6SSs present in reference S. Dublin str. CT_02021853 including
T6SSSPI-6 (Locus_tag: SeD_A0289 - SeD_A0326) and T6SSSPI-19 (Locus_tag: SeD_A1212 - SeD_A1243) are present in all clinical and veterinary isolates
from France. The virulence plasmid pCT02021853_74 (accession number: NC_011204.1) was detected in all S. Dublin isolates expect three clinical
isolates including 93.1557 from stool and 93.3170 and 201,005,507 from blood
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harbours a closely related plasmid to the virulence
plasmid pCT02021853 the plasmid does not harbour
the virulence spv locus. We therefore conclude that it
is unlikely that the virulence plasmid is the main
virulence determinant for S. Dublin and it is not crit-
ical for bacterial invasiveness since it is absent from
two invasive clinical isolates from blood; 93.3170 and
05.1078.
Among the virulence factors that might contribute to the
virulence of S. Dublin is γ-glutamyl transpeptidase (GGT)
as it has been reported to contribute to the virulence of
Helicobacter pylori [38] furthermore, it plays a significant
role in inhibiting T-cell proliferation [39]. We found that
the gene ggt is harboured by all S. Dublin isolates including
human and animal isolates.
Another virulence gene, PagN, encodes for an outer
membrane protein (PagN) that has been reported to con-
tribute to the virulence of S. Typhimurium through medi-
ating bacterial adhesion and invasion of mammalian cells
[40, 41]. Experimental studies showed that PagN is a
strong immuogen in mice and it can therefore be a poten-
tial vaccine candidate for salmonellosis [42]. Interestingly,
Fig. 4 Maximum-likelihood phylogenetic tree of S. Dublin strains from different countries; invasive clinical isolates are highlighted in grey,
gastroenteritis human isolates are highlighted in green and veterinary isolates are highlighted in yellow. The tree is based on SNPs determined
from the whole genome sequence. Tree was inferred by using a general time-reversible (GTR) model. Bootstrap support values, given as a percentage
of 1000 replicates, are shown above the branches
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we found that PagN is harboured by all S. Dublin isolates
including invasive and non-invasive isolates suggesting its
relation to bacterial virulence and invasiveness.
Although S. Dublin is adapted to cattle as a result of
extensive genome decay and pseudogenes accumulation
[6] S. Dublin can infect other animals [43, 44]. The
phylogenetic SNP analysis showed the close relation
among the veterinary isolates and human isolates as
SNPs were randomly distributed around the chromo-
some of S. Dublin. All S. Dublin isolates were intermixed
and there were no genomic differences among clinical
invasive and non-invasive isolates.
Conclusions
We identified several virulence factors in S. Dublin isolates
that form the bacterial invasome however, we could not
detect any genomic markers that differentiate invasive
from non-invasive disease suggesting that host factors and
immune response play a significant role in the disease
outcome.
Additional file
Additional file 1: Table S1. Distribution of putative virulence factors
among S. Dublin isolates. (XLSX 13 kb)
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